AU2001237768A1 - Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis - Google Patents

Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis

Info

Publication number
AU2001237768A1
AU2001237768A1 AU2001237768A AU3776801A AU2001237768A1 AU 2001237768 A1 AU2001237768 A1 AU 2001237768A1 AU 2001237768 A AU2001237768 A AU 2001237768A AU 3776801 A AU3776801 A AU 3776801A AU 2001237768 A1 AU2001237768 A1 AU 2001237768A1
Authority
AU
Australia
Prior art keywords
cirrhosis
prevention
treatment
liver fibrosis
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237768A
Other languages
English (en)
Inventor
Keon Wook Kang
Sang Geon Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001237768A1 publication Critical patent/AU2001237768A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001237768A 2000-03-02 2001-03-02 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis Abandoned AU2001237768A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20000010540 2000-03-02
KR0010540 2000-03-02
PCT/KR2001/000320 WO2001064215A1 (en) 2000-03-02 2001-03-02 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis

Publications (1)

Publication Number Publication Date
AU2001237768A1 true AU2001237768A1 (en) 2001-09-12

Family

ID=36776473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237768A Abandoned AU2001237768A1 (en) 2000-03-02 2001-03-02 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis

Country Status (10)

Country Link
EP (1) EP1263435B1 (pt)
JP (1) JP4226246B2 (pt)
CN (1) CN1218698C (pt)
AT (1) ATE332693T1 (pt)
AU (1) AU2001237768A1 (pt)
BR (1) BR0108732A (pt)
DE (1) DE60121426T2 (pt)
ES (1) ES2267722T3 (pt)
RU (1) RU2250768C2 (pt)
WO (1) WO2001064215A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030067935A (ko) * 2002-02-09 2003-08-19 김상건 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
KR100629771B1 (ko) * 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
KR100604261B1 (ko) 2004-10-11 2006-07-28 재단법인서울대학교산학협력재단 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-ｃ]피리딘-3-티온계 화합물
WO2007131973A2 (en) * 2006-05-11 2007-11-22 Prendergast Patrick T Compositions and methods for modulating the immune system

Also Published As

Publication number Publication date
WO2001064215A1 (en) 2001-09-07
JP4226246B2 (ja) 2009-02-18
JP2004538239A (ja) 2004-12-24
CN1407891A (zh) 2003-04-02
CN1218698C (zh) 2005-09-14
EP1263435A4 (en) 2004-08-11
DE60121426T2 (de) 2007-02-22
DE60121426D1 (de) 2006-08-24
EP1263435A1 (en) 2002-12-11
ES2267722T3 (es) 2007-03-16
ATE332693T1 (de) 2006-08-15
RU2002126216A (ru) 2004-03-20
EP1263435B1 (en) 2006-07-12
RU2250768C2 (ru) 2005-04-27
BR0108732A (pt) 2002-12-17

Similar Documents

Publication Publication Date Title
MY129406A (en) Taste masked liquid pharmaceutical compositions
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
WO2004043363A8 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
HUP0302508A3 (en) Pyridazinones and triazinones and their use as active ingredients of pharmaceutical compositions
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
WO2003028715A3 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
DE69919533D1 (de) Proteinhaltige arzneimittel
BG106155A (en) Novel derivatives and analogues of galanthamin
WO2005065639A3 (en) Novel pharmaceutical compositions
MY131488A (en) Low dose liquid entecavir formulations and use
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
CA2473202A1 (en) Pharmaceutical composition for regeneration of cirrhotic liver
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU2001237768A1 (en) Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
EP1254898A4 (en) BENZO-CONDENSED HETEROCYCLIC DERIVATIVES AND THESE MEDICINES CONTAINING ACTIVE SUBSTANCES
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
GEP20043377B (en) Pharmaceutical Complex